XML 45 R35.htm IDEA: XBRL DOCUMENT
v3.24.3

Business Segment (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Segment Reporting [Abstract] |
Schedule of Net Sales Information by Product Line | These product lines' net sales are as follows:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Orthopedic surgery | $ | 130,537 |  |  | $ | 124,667 |  |  | $ | 404,986 |  |  | $ | 396,633 |
General surgery | 186,164 |  |  | 179,911 |  |  | 556,085 |  |  | 521,066 |
Consolidated net sales | $ | 316,701 |  |  | $ | 304,578 |  |  | $ | 961,071 |  |  | $ | 917,699 |

X
- Definition Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 + Details
Name: | us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration